Inventor · disambiguated record
Zhengxia Chen
Also filed as: CHEN ZHENGXIA
18 granted patents·5 pending applications·17 citations·filing 2013–2023
88Inventor score
Files withCGENETECH SUZHOU CHINA CO LTD3MEDSHINE DISCOVERY INC3MERCK SHARP & DOHME3CHONGQING PHARMACEUTICAL INDUSTRIAL RES INSTITUTE CO LTD2GUANGDONG RAYNOVENT BIOTECH CO LTD2
Top patents by PatentIndex Score
23 records- 0187US10519133B2Vinyl compounds as FGFR and VEGFR inhibitorsMEDSHINE DISCOVERY INC·Filed 2016·Granted Dec 31, 2019·4 cites·16 claims
- 0281US12378241B2Pyridine derivative as FGFR and VEGFR dual inhibitorsCGENETECH SUZHOU CHINA CO LTD·Filed 2020·Granted Aug 5, 2025·1 cites·20 claims
- 0378US9527875B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2013·Granted Dec 27, 2016·4 cites·13 claims
- 0477US9834563B2Antidiabetic substituted heteroaryl compoundsMERCK SHARP & DOHME·Filed 2014·Granted Dec 5, 2017·4 cites·13 claims
- 0573US12297197B2Pyrazolopyridine compound as RET inhibitor and application thereofGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2020·Granted May 13, 2025·1 cites·19 claims
- 0673US11008292B2FGFR4 inhibitor and preparation method and use thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2017·Granted May 18, 2021·1 cites·15 claims
- 0768US10654808B2Tyrosine kinase inhibitor and pharmaceutical composition comprising sameGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted May 19, 2020·1 cites·21 claims
- 0865US11161817B2Quinoline derivative and use thereof as tyrosine kinase inhibitorCHONGQING PHARMACEUTICAL INDUSTRIAL RES INSTITUTE CO LTD·Filed 2018·Granted Nov 2, 2021·1 cites·9 claims
- 0965US2025282798A1Heteroaryl-substituted bicyclic compound and use thereofMEDSHINE DISCOVERY INC·Filed 2023·Application pending·0 cites
- 1063US2025295642A1Fluoroquinoxalinone derivative for selectively inhibiting parp1MEDSHINE DISCOVERY INC·Filed 2023·Application pending·0 cites
- 1159US11919898B2Crystal form of azaindole derivative and use thereofWUXI LIFE FOUNTAIN BIOTECH CO LTD·Filed 2021·Granted Mar 5, 2024·0 cites·18 claims
- 1257US2024409534A1Crystal form of methylpyrazole-substituted pyridoimidazole compound and preparation method thereforCGENETECH SUZHOU CHINA CO LTD·Filed 2022·Application pending·0 cites
- 1352US2023106064A1Crystalline form of fluvatinib or fluvatinib methanesulfonate and preparation method thereforCHONGQING PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2021·Application pending·0 cites
- 1451US12325703B2Fused ring compound as FGFR and VEGFR dual inhibitorCGENETECH SUZHOU CHINA CO LTD·Filed 2020·Granted Jun 10, 2025·0 cites·17 claims
- 1551US11440903B2Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 13, 2022·0 cites·26 claims
- 1646US11078194B2Salt form and crystal form serving as FGFR and VEGFR inhibitor compounds, and preparation method thereforHARBIN ZHENBAO PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 3, 2021·0 cites·10 claims
- 1745US12312347B2Azaindole derivative and use thereof as FGFR and C-Met inhibitorWUXI LIFE FOUNTAIN BIOTECH CO LTD·Filed 2019·Granted May 27, 2025·0 cites·18 claims
- 1845US11236094B2Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitorsCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·20 claims
- 1945US2022175756A1Application of combination of quinoline derivative and immunomodulator in preparation of antitumor drugsCHONGQING PHARMACEUTICAL INDUSTRIAL RES INSTITUTE CO LTD·Filed 2020·Application pending·0 cites
- 2042US10766862B2Crystal form and salt form of and preparation method for tyrosine kinase inhibitorGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2017·Granted Sep 8, 2020·0 cites·15 claims
- 2141US12509440B2Fluorovinylbenzamide compound as PD-L1 immunomodulatorNOVAONCO JS THERAPEUTICS CO LTD·Filed 2020·Granted Dec 30, 2025·0 cites·7 claims
- 2240US12152013B2Vinylpyridine carboxamide compound as PD-L1 immunomodulatorNOVAONCO JS THERAPEUTICS CO LTD·Filed 2020·Granted Nov 26, 2024·0 cites·14 claims
- 2334US10000454B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Jun 19, 2018·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Zhengxia Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →